This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a critical role in the development of drugs targeting neurological and psychiatric disorders, particularly those involving neurotransmitter modulation. Its structure, featuring a fluorophenyl group, makes it valuable for creating compounds with enhanced binding affinity and selectivity for specific receptors in the brain. Additionally, it is used in research to study the pharmacological effects of chiral molecules, aiding in the design of more effective and safer therapeutic agents. Its application extends to the production of enantiomerically pure substances, which are essential for minimizing side effects in drug formulations.